Baillie Gifford WW Health Innovation Fund Class A USD AccRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | -8.4 | -25.1 | -17.2 | 1.5 | |
+/-Cat | - | -17.8 | -20.4 | -14.1 | -3.7 | |
+/-B’mrk | - | -26.6 | -30.9 | -14.7 | -6.5 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 19/04/2024 | USD 8.82 | |
Day Change | -1.10% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | IE00BKMG4D66 | |
Fund Size (Mil) 19/04/2024 | USD 171.03 | |
Share Class Size (Mil) 19/04/2024 | USD 4.02 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 14/02/2024 | 1.65% |
Investment Objective: Baillie Gifford WW Health Innovation Fund Class A USD Acc |
The investment objective of the Fund is to provide strong returns over the long term by investing primarily in a global equity portfolio selected from companies engaged in the healthcare industry and that promotes better healthcare outcomes by driving real change for patients and the healthcare system and evidence care about patients. The Fund may also invest in other transferable securities, money market instruments, cash and cash equivalents. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Julia Angeles 01/10/2018 | ||
Marina Record 01/10/2018 | ||
Click here to see others | ||
Inception Date 28/02/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR EUR | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Baillie Gifford WW Health Innovation Fund Class A USD Acc | 29/02/2024 |
|
|
Top 5 Holdings | Sector | % |
Shockwave Medical Inc | Healthcare | 6.59 |
Moderna Inc | Healthcare | 6.14 |
Genmab A/S | Healthcare | 5.92 |
argenx SE | Healthcare | 5.50 |
Ambu A/S Class B | Healthcare | 5.16 |
Increase Decrease New since last portfolio | ||
Baillie Gifford WW Health Innovation Fund Class A USD Acc |